Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Seegene y la Agencia de Seguridad Sanitaria del Reino Unido convocan una cumbre

      Logo

      News provided by

      Seegene Inc.

      Apr 16, 2024, 03:49 ET

      Share this article

      Share this article


      - Seegene y la Agencia de Seguridad Sanitaria del Reino Unido convocan una cumbre para colectivamente hacer realidad "un mundo libre de enfermedades"

      • Dos directores generales se reunieron en la sede de Seegene para debatir la visión de Seegene, con la que coincidieron totalmente
      • Se presentó la respuesta rápida de Seegene a la pandemia de la COVID-19 y las soluciones digitales a través de la implementación de la IA

      SEÚL, Corea del Sur, 16 de abril de 2024 /PRNewswire/ -- Seegene Inc, empresa surcoreana líder en soluciones integrales para el diagnóstico molecular por PCR, ha anunciado hoy que Dame Jenny Harries, Jefa Ejecutiva de la Agencia de Seguridad Sanitaria del Reino Unido (UKHSA), visitó su sede central en Seúl, Corea, el 27 de marzo.

      Continue Reading
      Seegene Founder & CEO Dr. Jong-Yoon Chun, left, and CEO of UK Health Security Agency (UKHSA) Prof. Dame Jenny Harries, far right, discuss ways to realize 'a world free from all diseases' at Seegene headquarters in Seoul on March 27.
      Seegene Founder & CEO Dr. Jong-Yoon Chun, left, and CEO of UK Health Security Agency (UKHSA) Prof. Dame Jenny Harries, far right, discuss ways to realize 'a world free from all diseases' at Seegene headquarters in Seoul on March 27.
      Seegene Founder & CEO Dr. Jong-Yoon Chun, left, poses for a photo with Prof. Dame Jenny Harries, CEO of the UK Health Security Agency (UKHSA) after a meeting at Seegene headquarters in Seoul on March 27.
      Seegene Founder & CEO Dr. Jong-Yoon Chun, left, poses for a photo with Prof. Dame Jenny Harries, CEO of the UK Health Security Agency (UKHSA) after a meeting at Seegene headquarters in Seoul on March 27.

      Según la empresa, la profesora Harries y su delegación mantuvieron conversaciones con el doctor Jong-Yoon Chun, fundador y consejero delegado de Seegene, y con el equipo directivo, en las que se expresó la firme voluntad de avanzar colectivamente para hacer realidad la visión de Seegene de "un mundo libre de enfermedades".

      La profesora Harries expresó un gran interés en el proyecto SG OneSystemTM de Seegene, la iniciativa de intercambio de tecnología de la empresa, así como sus avances en el sistema automatizado de desarrollo de reactivos de diagnóstico, impulsado por la inteligencia artificial (IA) y por las soluciones digitales innovadoras que integran la biotecnología (BT) y la tecnología de la información (TI).

      Destacando la rápida respuesta de Seegene a la pandemia de la Covid-19, la profesora Harries elogió la agilidad de la empresa para desarrollar reactivos de diagnóstico en sólo tres semanas y distribuirlos por todo el mundo. "Creemos firmemente que la velocidad de desarrollo de los ensayos debe ser mayor que la velocidad de la transmisión", explicó el doctor Chun, reflexionando sobre los retos durante la pandemia. "Actuamos con rapidez utilizando las autorizaciones de emergencia de los gobiernos de todo el mundo y aprovechando la red de distribución mundial que habíamos creado antes de la pandemia".

      Seegene ha facilitado el aislamiento rápido y eficaz de las personas que se han visto infectadas por la COVID-19 mediante el suministro de aproximadamente 350 millones de pruebas de diagnóstico a más de 100 países.

      "Valoramos enormemente la visita de UKHSA, una agencia de seguridad sanitaria líder en el mundo, a Seegene", declaró el doctor Chun. "Seguiremos explorando vías para contribuir a la cooperación entre Corea y el Reino Unido, incluyendo nuestro proyecto SG OneSystemTM ", añadió.

      El proyecto SG OneSystemTM, iniciativa para compartir la tecnología de Seegene, es una estrategia global destinada a erradicar enfermedades. Consiste en difundir la tecnología de PCR cuantitativa sindrómica de la empresa y el Sistema de Desarrollo Digitalizado de Seegene (SGDDS) a empresas líderes. La iniciativa permite a científicos de todo el mundo contribuir directamente al desarrollo de reactivos de diagnóstico adaptados localmente para diversas enfermedades que afectan a seres humanos, animales y plantas.

      Para avanzar eficazmente en este empeño, Seegene ha forjado colaboraciones estratégicas con líderes de la industria y del mundo académico, entre ellos Microsoft y Springer Nature, subrayando así su compromiso con el avance de las soluciones sanitarias mundiales a través de la mejora de su iniciativa de intercambio de tecnología.

      Acerca de Seegene
      Seegene cuenta con 23 años de experiencia dedicada a la I+D, la fabricación y el negocio en torno a las tecnologías de PCR cuantitativa sindrómica, que se puso de manifiesto durante la pandemia de la COVID-19, cuando suministró más de 340 millones de pruebas de la COVID-19 a más de 100 países de todo el mundo. La característica principal de las tecnologías PCR sindrómicas únicas de Seegene es la capacidad de analizar simultáneamente 14 patógenos que causan síntomas similares en un solo tubo y proporcionar información cuantitativa sobre el perfil de infectividad para correlacionarlo con la gravedad de la enfermedad. 

      Foto - https://mma.prnewswire.com/media/2381076/Image__UKHSA2.jpg
      Foto - https://mma.prnewswire.com/media/2381077/Image__UKHSA1.jpg
      Logo - https://mma.prnewswire.com/media/1357790/Seegene_logo_Logo.jpg 

      Modal title

      Also from this source

      Seegene propose une approche globale de dépistage des infections de l'appareil génital dans le cadre de la Global Million Clinical Study (GMCS)

      Seegene propose une approche globale de dépistage des infections de l'appareil génital dans le cadre de la Global Million Clinical Study (GMCS)

      Seegene Inc., une société internationale spécialisée dans le diagnostic moléculaire, annonce la mise au point d'une approche complète de dépistage...

      Seegene stellt im Rahmen der Global Million Clinical Study (GMCS) einen ganzheitlichen Ansatz für die Diagnostik von Infektionen des Genitaltrakts vor

      Seegene stellt im Rahmen der Global Million Clinical Study (GMCS) einen ganzheitlichen Ansatz für die Diagnostik von Infektionen des Genitaltrakts vor

      Seegene Inc., ein weltweit führendes Unternehmen im Bereich der molekularen Diagnostik, kündigte einen umfassenden syndromischen PCR-basierten Ansatz ...

      More Releases From This Source

      Explore

      Pharmaceuticals

      Pharmaceuticals

      Health Care & Hospitals

      Health Care & Hospitals

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Artificial Intelligence

      Artificial Intelligence

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.